Mabini, Simeon A.

HRN: 29-27-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2026
CO-AMOXICLAV 625MG (TAB)
07/07/2026
07/14/2026
PO
625mg
TID
Pressure Ulcer Stage 3
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines